logo
  

International Paper Says No Comments On Rumors Amid Strategic Initiatives And DS Smith Merger Plans

International Paper (IP) said it adheres to its standard policy of refraining from commenting on rumors or speculation circulating in recent media reports. Under the leadership of new CEO Andy Silvernail, the IP team is actively implementing business strategies and pursuing commercial and cost improvement initiatives across its portfolio.

International Paper said it remains committed to completing its previously announced merger with DS Smith.

Earlier today, Reuters reported that International Paper has been approached by Suzano with an offer to buy the Memphis paper conglomerate for about $15 billion.
If the companies move ahead with the deal, it could disrupt International Paper's pending acquisition of U.K. company DS Smith. IP outbid rival Monty Plc for the deal.

Last month, International Paper and DS Smith reached agreement on the terms of a recommended all-share combination. The terms of the combination values each DS Smith share at 415 pence per share, and will result in IP issuing 0.1285 shares for each DS Smith share, resulting in pro forma ownership of 66.3 percent for IP shareholders and 33.7 percent for DS Smith shareholders, implying a transaction value of approximately $9.9 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Nvidia Corp. has breached the $3 trillion mark in valuation, becoming the second most valuable company in the U.S. Market overtaking tech giant Apple Inc on Wednesday. The artificial intelligence or AI chipmaker is gaining on the surging demand for AI chips worldwide. Madrigal Pharmaceuticals, Inc. (MDGL), Thursday announced that its Phase 3 MAESTRO-NASH biopsy trial using Rezdiffra achieved both fibrosis improvement and NASH resolution primary endpoints. Further, 80 percent of patients treated with Rezdiffra 100 mg experienced improvement or stabilization of fibrosis.... HomeoCare Laboratories Inc. is recalling two batches of Homeopathic StellaLife Oral Care Products citing microbial contamination, according to the U.S. Food and Drug Administration. The recall involves Homeopathic Stella Life Vega Oral Care Spray Unflavored and Advanced Formula Peppermint Oral Care Rinse manufactured in 2024.

The highlight this week was the latest set of first quarter economic growth figures from the U.S. Find out why the data damped the market sentiment. Other main releases from the U.S. included those on consumer confidence and jobless claims. In Europe, German inflation figures caught everyone's attention. Learn why it added to expectations of rate staying “higher for longer”. Asia's economics scene this week was dominated by the release of PMI survey figures from China.

View More Videos
Follow RTT